14.55
price up icon2.39%   0.34
pre-market  Vorhandelsmarkt:  14.38   -0.17   -1.17%
loading

Phathom Pharmaceuticals Inc Aktie (PHAT) Neueste Nachrichten

pulisher
Dec 09, 2025

Barclays Initiates Coverage of Phathom Pharmaceuticals (PHAT) with Equal-Weight Recommendation - Nasdaq

Dec 09, 2025
pulisher
Dec 09, 2025

Barclays Initiates Phathom Pharmaceuticals at Equalweight With $16 Price Target - marketscreener.com

Dec 09, 2025
pulisher
Dec 06, 2025

Is WPIL Limited Still a Good Stock to Buy After Recent Earnings - earlytimes.in

Dec 06, 2025
pulisher
Nov 30, 2025

Responsive Playbooks and the PHAT Inflection - news.stocktradersdaily.com

Nov 30, 2025
pulisher
Nov 28, 2025

Phathom Pharmaceuticals stock hits 52-week high at 16.08 USD By Investing.com - Investing.com Nigeria

Nov 28, 2025
pulisher
Nov 28, 2025

Phathom Pharmaceuticals stock hits 52-week high at 16.08 USD - Investing.com

Nov 28, 2025
pulisher
Nov 27, 2025

Is Phathom Pharmaceuticals Inc a good long term investmentIPO Market Watch & Budget Friendly Capital Growth - earlytimes.in

Nov 27, 2025
pulisher
Nov 27, 2025

How Phathom Pharmaceuticals Inc. stock benefits from strong dollarJuly 2025 Earnings & Accurate Intraday Trading Signals - moha.gov.vn

Nov 27, 2025
pulisher
Nov 24, 2025

Phathom Pharmaceuticals research links GLP-1 use to higher GERD risk - Traders Union

Nov 24, 2025
pulisher
Nov 21, 2025

Phathom Pharmaceuticals Inc. (PHAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

Phathom Pharmaceuticals: Superior Efficacy Drives Vonoprazan Growth (NASDAQ:PHAT) - Seeking Alpha

Nov 21, 2025
pulisher
Nov 20, 2025

What Wall Street predicts for Phathom Pharmaceuticals Inc. stock priceJuly 2025 Macro Moves & Safe Entry Momentum Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Phathom Pharmaceuticals Inc. stock a contrarian buyGap Up & Daily Growth Stock Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Phathom Pharmaceuticals Inc. stock a smart buy before Fed meeting2025 Market Overview & Fast Moving Stock Trade Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What margin trends mean for Phathom Pharmaceuticals Inc. stockJuly 2025 Summary & Daily Stock Momentum Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Phathom Pharmaceuticals Inc. stock positioned for digital transformation2025 Market Sentiment & Safe Entry Trade Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Understanding the Setup: (PHAT) and Scalable Risk - news.stocktradersdaily.com

Nov 19, 2025
pulisher
Nov 19, 2025

Comparing Phathom Pharmaceuticals Inc. in custom built stock radarsJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Volume spikes in Phathom Pharmaceuticals Inc. stock – what they meanMarket Risk Analysis & Growth Oriented Trade Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Phathom Pharmaceuticals Inc. stock reach all time highs in 20252025 Top Decliners & Proven Capital Preservation Methods - newser.com

Nov 19, 2025
pulisher
Nov 16, 2025

Volatility clustering patterns for Phathom Pharmaceuticals Inc.July 2025 Review & Capital Efficiency Focused Strategies - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Why Phathom Pharmaceuticals Inc. stock remains a top recommendationTrade Volume Summary & Stock Market Timing Techniques - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Is Phathom Pharmaceuticals Inc. stock a buy on dipsGlobal Markets & Community Shared Stock Ideas - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Can Phathom Pharmaceuticals Inc. recover in the next quarterJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

Strong Week for Phathom Pharmaceuticals (NASDAQ:PHAT) Shareholders Doesn't Alleviate Pain of Five-year Loss - 富途牛牛

Nov 13, 2025
pulisher
Nov 13, 2025

How sentiment analysis helps forecast Phathom Pharmaceuticals Inc. - newser.com

Nov 13, 2025
pulisher
Nov 12, 2025

Could Clinical Progress With VOQUEZNA Reshape Phathom Pharmaceuticals’ Long-Term Strategy (PHAT)? - Yahoo Finance

Nov 12, 2025
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):